Asosiy kontentga oʻtish
Maqola

“GEPA-SEEM” kombinatsiyalangan infuzion eritmasining YUXXS usullarini validatsiya qilish va sifatini ta’minlash

Sunnatulla TugizboevG‘olib Toshev“SAMARKAND-ENGLAND ECO-MEDICAL” QK MChJCharos ToshtemirovaTashkent Pharmaceutical InstituteVolidakhon UmirdinovaToshkent farmatsevtika institutiSevara KhazratkulovaSunnatulla TugizboevG‘olib ToshevVolidakhon UmirdinovaSevara KhazratkulovaSunnatulla Tugizboyev“SAMARKAND-ENGLAND ECO-MEDICAL” QK MChJG‘olib Toshev“SAMARKAND-ENGLAND ECO-MEDICAL” QK MChJVolidaxon UmirdinovaToshkent farmatsevtika institutiSevara XazratqulovaToshkent farmatsevtika instituti
2026uz
ABI

Annotatsiya

This article discusses the development and full validation of high-performance liquid chromatography (HPLC) methods for the active pharmaceutical ingredients (APIs) of the combined infusion solution “GEPA-SEEM”—monoammonium glycyrrhizinate (MAG), glycine, and L-cysteine hydrochloride—as well as the development of a company pharmacopoeial monograph in accordance with the requirements of the State Pharmacopoeia of the Republic of Uzbekistan and the ICH Q2(R1) guideline. The validated HPLC methods are suitable for routine quality control of the “GEPA-SEEM” infusion solution and comply with the requirements of the State Pharmacopoeia of the Republic of Uzbekistan and the European Pharmacopoeia. The developed company pharmacopoeial monograph may serve as a regulatory basis for registration of the medicinal product in the Republic of Uzbekistan.

Identifikatorlar

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba